Bionano announces presentation of optical genome mapping (ogm) utility across cancer research applications at the cancer genomics consortium (cgc) 2023 annual meeting

San diego, aug. 11, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced its participation at the cancer genomics consortium (cgc) 2023 annual meeting with a broad range of content covering the utility of optical genome mapping (ogm) for solid tumor and hematological malignancy cancer research, including scientific platform and poster presentations from bionano and a panel discussion featuring esteemed researchers from across the cancer genomics landscape.
BNGO Ratings Summary
BNGO Quant Ranking